WE GIVE SHAREHOLDERS A VOICE

Ampio Pharmaceuticals, Inc. Loss Form

See If You Qualify For Monetary Reward

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

Name *Please enter a name.

Email *Please enter a valid email.

Address

City

State

Zip

Daytime Phone

Evening Phone

Shares Owned

Purchase Date

Loss

Submit Transaction Detail Now (Optional)

Statement Information

- OR -

This submission does not create an attorney-client relationship. We will keep you up to date with this investigation, and should this investigation evolve, we will contact you to discuss whether to establish an attorney client relationship at no cost to you.

FAX: 212-363-7171

Levi & Korsinsky announces it has commenced an investigation of Ampio Pharmaceuticals, Inc. (“Ampio” or “the Company”) (NYSE American: AMPE) concerning possible violations of federal securities laws. On August 7, 2018, Ampio filed a Form 8-K with the U.S. Securities and Exchange Commission providing an update on the U.S. Food and Drug Administration’s review of the AP-003-A and AP-003-C trials. Ampio disclosed that it had met with the FDA in July and received a response letter, notifying the Company that the AP-003-A study alone “does not appear to provide sufficient evidence of effectiveness to support” its Biologics License Application. Following this news, shares of Ampio were down more than 78% on intraday trading on August 8, 2018.

Nicholas I. Porritt Partner

Nicholas I. Porritt, Partner

Mr. Porritt prosecutes securities class actions, shareholder class actions, derivative actions, and mergers and acquisitions litigations. As a qualified Solicitor of the Senior Courts of England & Wales, he advises international clients on the recovery of losses suffered in their investment portfolios.
Shannon L. Hopkins Partner

Shannon L. Hopkins, Partner

Ms. Hopkins manages the Firm’s Connecticut office. She has prosecuted a wide range of class action matters for over a decade, helping to recover millions in settlements on behalf of shareholders. Ms. Hopkins is also a Certified Public Accountant.
Joseph E. Levi Founding Partner

Joseph E. Levi, Founding Partner

Mr. Levi is a central figure in shaping and managing the Firm’s securities litigation practice. In addition to his efforts on behalf of shareholders, he has represented numerous patent holders in enforcing their patent rights.
Eduard Korsinsky Founding Partner

Eduard Korsinsky, Founding Partner

Mr. Korsinsky is a Managing Partner of the Firm. He has served as an Editor of the American Bar Association’s Securities Litigation Section newsletter. He represents clients in securities cases, derivative actions, consumer fraud and complex commercial matters.
Donald J. Enright Partner

Donald J. Enright, Partner

Mr. Enright’s practice focuses on shareholder mergers and acquisitions and securities fraud class action litigation. He has also handled matters in commodities, consumer fraud, and commercial litigation. He has served in a leadership role in numerous actions, yielding multi-million dollar recoveries for shareholder classes.
Nancy A. Kulesa Partner

Nancy A. Kulesa, Partner

Ms. Kulesa’s practice focuses on securities litigation and institutional investor relations. She directs the Firm’s Portfolio Monitoring Services, assisting clients in identifying losses in their securities portfolios that were caused by corporate wrongdoing.

THE POWERHOUSE